Bajaj Finance Ltd is quoting at Rs 6923.85, up 2.41% on the day as on 12:44 IST on the NSE. The stock is up 23.79% in last one year as compared to a 29.81% spurt in NIFTY and a 17.77% spurt in the Nifty Financial Services.
Posts in category Business Standard
IndiGo rallies 4% to hit fresh high, stock zooms 79% thus far in FY24 (26-03-2024)
IndiGo plans to add 10 new destinations in fiscal 2025 and manage a fleet of more than 600 aircraft by 2030 as it expects the number of fliers in India to more than double by the end of the decade
Board of TVS Supply Chain Solutions approves conversion of loan to equity in its overseas subsidiary (26-03-2024)
At meeting held on 25 March 2024
Indices trade with minor cuts; oil & gas shares in demand (26-03-2024)
At 12:30 IST, the barometer index, the S&P BSE Sensex was down 215.29 points or 0.29% to 72,618.59. The Nifty 50 index lost 43.15 points or 0.20% to 22,053.60.
Smallcap stock zooms 10% as SBI MF buys 3% stake; HDFC MF holds 7% equity (26-03-2024)
Among non-promoter public shareholders, HDFC Mutual fund (via HDFC Balanced Advantage Fund) held 7.4 per cent stake in Savita Oil, according to data on BSE
Hindustan Media Ventures Ltd leads gainers in ‘B’ group (26-03-2024)
Onelife Capital Advisors Ltd, Permanent Magnets Ltd, Vishal Bearings Ltd and Deep Industries Ltd are among the other gainers in the BSE’s ‘B’ group today, 26 March 2024.
H.G. Infra rises on bagging solar project worth Rs 534 cr (26-03-2024)
H.G. Infra Engineering gained 2.26% to Rs 918.55 after its consortium Stockwell Solar Services received a solar project worth Rs 534 crore from Jodhpur Vidyut Vitran Nigam.
Sanghvi Movers Ltd leads gainers in ‘A’ group (26-03-2024)
Time Technoplast Ltd, Electrosteel Castings Ltd, Indo Count Industries Ltd and Apar Industries Ltd are among the other gainers in the BSE’s ‘A’ group today, 26 March 2024.
Dr. Reddy’s Lab enters into marketing licensing agreement with Pharmazz for Centhaquine (26-03-2024)
Dr. Reddy’s Laboratories said that it has entered into a license agreement with Pharmazz Inc. to commercialise the first-in-class innovative drug Centhaquine in India.
Mankind Pharma slips 4% on Beige’s likely 3% stake sale via block deal (26-03-2024)
According to media reports, Beige Ltd, an affiliate of private equity firm ChrysCapital, was looking to offload 2.90 per cent stake in the drugmaker through block deals